JP2012531409A5 - - Google Patents

Download PDF

Info

Publication number
JP2012531409A5
JP2012531409A5 JP2012517454A JP2012517454A JP2012531409A5 JP 2012531409 A5 JP2012531409 A5 JP 2012531409A5 JP 2012517454 A JP2012517454 A JP 2012517454A JP 2012517454 A JP2012517454 A JP 2012517454A JP 2012531409 A5 JP2012531409 A5 JP 2012531409A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
use according
naproxen
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012517454A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012531409A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2010/050712 external-priority patent/WO2010151216A1/en
Publication of JP2012531409A publication Critical patent/JP2012531409A/ja
Publication of JP2012531409A5 publication Critical patent/JP2012531409A5/ja
Pending legal-status Critical Current

Links

JP2012517454A 2009-06-25 2010-06-23 Nsaid関連潰瘍を発症するリスクがある患者の処置方法 Pending JP2012531409A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22042009P 2009-06-25 2009-06-25
US61/220,420 2009-06-25
US22597009P 2009-07-16 2009-07-16
US61/225,970 2009-07-16
US31052510P 2010-03-04 2010-03-04
US61/310,525 2010-03-04
PCT/SE2010/050712 WO2010151216A1 (en) 2009-06-25 2010-06-23 Method for treating a patient at risk for developing an nsaid-associated ulcer

Publications (2)

Publication Number Publication Date
JP2012531409A JP2012531409A (ja) 2012-12-10
JP2012531409A5 true JP2012531409A5 (2) 2013-08-01

Family

ID=43381035

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012517454A Pending JP2012531409A (ja) 2009-06-25 2010-06-23 Nsaid関連潰瘍を発症するリスクがある患者の処置方法

Country Status (13)

Country Link
US (3) US8945621B2 (2)
EP (1) EP2445499A4 (2)
JP (1) JP2012531409A (2)
KR (1) KR20120030106A (2)
CN (1) CN102481293A (2)
AU (1) AU2010263304A1 (2)
CA (1) CA2764963C (2)
EA (1) EA201290026A1 (2)
IL (1) IL216877A0 (2)
MA (1) MA33553B1 (2)
MX (1) MX2011013467A (2)
SG (1) SG176724A1 (2)
WO (1) WO2010151216A1 (2)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US9220698B2 (en) 2008-09-09 2015-12-29 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
US8435545B2 (en) 2011-09-01 2013-05-07 Qualicaps, Inc. Capsule having broad color spectrum
US8420057B2 (en) 2011-09-01 2013-04-16 Qualicaps, Inc. Capsule having broad color spectrum
EP2797600A4 (en) 2011-12-28 2015-09-16 Pozen Inc IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID
US10758618B2 (en) 2015-02-10 2020-09-01 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10722583B2 (en) 2015-02-10 2020-07-28 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11602563B2 (en) 2015-02-10 2023-03-14 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10537642B1 (en) 2015-02-10 2020-01-21 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10780166B2 (en) 2015-02-10 2020-09-22 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11013806B2 (en) 2015-02-10 2021-05-25 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10653777B2 (en) 2015-02-10 2020-05-19 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11045549B2 (en) 2015-02-10 2021-06-29 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11110173B2 (en) 2015-02-10 2021-09-07 Axsome Therapeutics, Inc Pharmaceutical compositions comprising meloxicam
US12485176B2 (en) 2015-02-10 2025-12-02 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10780165B2 (en) 2015-02-10 2020-09-22 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10695430B2 (en) 2015-02-10 2020-06-30 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11013805B2 (en) 2015-02-10 2021-05-25 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10799588B2 (en) 2015-02-10 2020-10-13 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10933137B2 (en) 2015-02-10 2021-03-02 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10512692B2 (en) 2015-02-10 2019-12-24 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10695429B2 (en) 2015-02-10 2020-06-30 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10517950B1 (en) 2015-02-10 2019-12-31 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10933136B2 (en) 2015-02-10 2021-03-02 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11607456B2 (en) 2015-02-10 2023-03-21 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10729774B1 (en) 2015-02-10 2020-08-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11738085B2 (en) 2015-02-10 2023-08-29 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10729773B2 (en) 2015-02-10 2020-08-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10821181B2 (en) 2015-02-10 2020-11-03 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10532101B1 (en) 2015-02-10 2020-01-14 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10702602B2 (en) 2015-02-10 2020-07-07 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10058614B2 (en) 2015-02-10 2018-08-28 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10729696B2 (en) 2017-01-04 2020-08-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11471465B2 (en) 2017-01-04 2022-10-18 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10940153B2 (en) 2017-01-04 2021-03-09 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
SI3565550T1 (sl) 2017-01-04 2021-04-30 Axsome Therapeutics, Inc. Farmacevtske sestave, ki vsebujejo meloksikam in rizatriptan
US10729697B2 (en) 2017-01-04 2020-08-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11806354B2 (en) 2017-01-04 2023-11-07 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11266657B2 (en) 2017-01-04 2022-03-08 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11801250B2 (en) 2017-01-04 2023-10-31 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11433078B2 (en) 2017-01-04 2022-09-06 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10894053B2 (en) 2017-01-04 2021-01-19 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11207327B2 (en) 2017-01-04 2021-12-28 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10905693B2 (en) 2017-01-04 2021-02-02 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10583088B2 (en) 2017-01-04 2020-03-10 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11617755B2 (en) 2017-01-04 2023-04-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10471014B2 (en) 2017-01-04 2019-11-12 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10821182B2 (en) 2017-06-29 2020-11-03 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11433079B2 (en) 2017-01-04 2022-09-06 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10583144B2 (en) 2017-01-04 2020-03-10 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10561664B1 (en) 2017-01-04 2020-02-18 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11617756B2 (en) 2017-06-29 2023-04-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10688185B2 (en) 2017-06-29 2020-06-23 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11759522B2 (en) 2017-06-29 2023-09-19 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10758617B2 (en) 2017-06-29 2020-09-01 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10987358B2 (en) 2017-06-29 2021-04-27 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11510927B2 (en) 2017-06-29 2022-11-29 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10918722B2 (en) 2017-06-29 2021-02-16 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10512693B2 (en) 2017-06-29 2019-12-24 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11219626B2 (en) 2017-06-29 2022-01-11 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11617791B2 (en) 2017-06-29 2023-04-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11185550B2 (en) 2017-06-29 2021-11-30 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10688102B2 (en) 2017-06-29 2020-06-23 Axsome Therapeutics, Inc. Combination treatment for migraine and other pain
US11865117B2 (en) 2017-06-29 2024-01-09 Axsome Therapeutics, Inc Pharmaceutical compositions comprising meloxicam
US20220249455A1 (en) * 2019-07-15 2022-08-11 R.P. Scherer Technologies, Llc Enteric proton pump inhibitor softgel capsule
US20240058354A1 (en) 2020-04-06 2024-02-22 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US12128052B2 (en) 2020-05-28 2024-10-29 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US20250319071A1 (en) * 2020-12-30 2025-10-16 Hk Inno.N Corporation Pharmaceutical composition comprising tegoprazan and non-steroidal anti-inflammatory drugs
EP4271386A4 (en) 2020-12-31 2024-11-13 Axsome Therapeutics, Inc. PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM
US12370196B2 (en) 2020-12-31 2025-07-29 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US12005118B2 (en) 2022-05-19 2024-06-11 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
WO2025207796A1 (en) * 2024-03-26 2025-10-02 The Medical College Of Wisconsin, Inc. Methods and compositions for treatment of peptic ulcers and/or peptic ulcer disease
US12544383B1 (en) 2025-01-30 2026-02-10 Axsome Therapeutics, Inc. Methods of treating migraines with a combination of a meloxicam and a rizatriptan

Family Cites Families (232)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
CH647676A5 (fr) 1978-12-22 1985-02-15 Donald E Panoz Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation.
US4198390A (en) 1979-01-31 1980-04-15 Rider Joseph A Simethicone antacid tablet
FR2470599A1 (fr) 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
US4344929A (en) 1980-04-25 1982-08-17 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
GB2105193B (en) 1981-09-04 1984-09-12 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
JPS59227870A (ja) 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規2−グアニジノチアゾリン誘導体ならびにその製造法
US4554276A (en) 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4522826A (en) 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4552899A (en) 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
IT1196190B (it) 1984-07-12 1988-11-10 Lisapharma Spa Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
US4766117A (en) 1984-10-11 1988-08-23 Pfizer Inc. Antiinflammatory compositions and methods
US4676984A (en) 1985-08-14 1987-06-30 American Home Products Corp. Rehydratable antacid composition
US4704278A (en) 1984-10-17 1987-11-03 American Home Products Corp (Del) Fluidized magaldrate suspension
DE3603576A1 (de) 1986-02-06 1987-08-13 Code Kaffee Handel Verwendung von gerbstoffen und/oder chlorogensaeure sowie nahrungs-, genuss- und/oder arzneimittel mit gerbstoff- und/oder chlorogensaeurezusatz
CA1327010C (en) 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
US4965065A (en) 1986-04-29 1990-10-23 Bristol-Myers Squibb Company Gastroprotective process and compositions
US4757060A (en) 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
US5037815A (en) 1986-03-04 1991-08-06 Bristol-Myers Squibb Co. Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers
US5043358A (en) 1986-03-04 1991-08-27 Bristol-Myers Squibb Company Gastroprotective process
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5260333A (en) 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
EP0320550A1 (en) 1987-12-18 1989-06-21 Bristol-Myers Company Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent
GB8805268D0 (en) 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
JPH0768125B2 (ja) 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
SE8804629D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
US4948581A (en) 1989-02-17 1990-08-14 Dojin Iyaku-Kako Co., Ltd. Long acting diclofenac sodium preparation
NZ235877A (en) 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
US5204118A (en) 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
AU8089091A (en) 1990-05-03 1991-11-27 G.D. Searle & Co. Pharmaceutical composition containing ibuprofen and a prostaglandin
DE69109286T2 (de) 1990-05-03 1995-09-28 Searle & Co Pharmazeutische zusammensetzung.
WO1991016896A1 (en) 1990-05-03 1991-11-14 G.D. Searle & Co. Pharmaceutical composition for use in treating pain
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
WO1991019712A1 (en) 1990-06-20 1991-12-26 Aktiebolaget Astra Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
JPH06506198A (ja) 1991-03-04 1994-07-14 ワーナー−ランバート・コンパニー 種々な剤形の非ステロイド性抗炎症剤の新規な塩/イオン対
US5409709A (en) 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
DK0550083T3 (da) 1991-12-06 1999-10-11 Glaxo Group Ltd Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
CA2125579C (en) 1991-12-17 2005-06-21 Richard C. Fuisz Ulcer prevention treatment composition and method
WO1993012817A1 (en) 1991-12-20 1993-07-08 Warner-Lambert Company Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
US5294433A (en) 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
GR1002332B (el) 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
WO1994007541A1 (en) 1992-09-29 1994-04-14 Merck & Co., Inc. Ibuprofen-h2 antagonist combinations
CA2110313C (en) 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
US5686105A (en) 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
DK66493D0 (da) 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
SE9302395D0 (sv) 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
SE9302396D0 (sv) 1993-07-09 1993-07-09 Ab Astra A novel compound form
US5514663A (en) 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
JP3725542B2 (ja) 1993-10-19 2005-12-14 大正製薬株式会社 ピコサルフェート剤形
US5643960A (en) 1994-04-15 1997-07-01 Duke University Method of delaying onset of alzheimer's disease symptoms
US6025395A (en) 1994-04-15 2000-02-15 Duke University Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
FR2719999B1 (fr) 1994-05-17 1996-08-02 Georges Serge Grimberg Composition pharmaceutique à base de gomme de guar et d'un antiacide neutralisant, à laquelle peut être ajoutée une série de principes actifs thérapeutiques.
TNSN95062A1 (fr) 1994-05-27 1996-02-06 Astra Ab Nouveaux derives dialkoxy-pyridinyle-benzimidazole
DK0723436T3 (da) 1994-07-08 2001-11-26 Astrazeneca Ab Tabletteret flerenhedsdoseringsform
US5702723A (en) 1994-08-02 1997-12-30 Griffin; David Multi-stage delivery system for ingestible medications or nutrients
AU3343295A (en) 1994-08-12 1996-03-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazopyridine salt
JP2896532B2 (ja) 1994-08-13 1999-05-31 ユーハン コーポレーション 新規なピリミジン誘導体およびその製造方法
ZA959469B (en) 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
EP1214940B1 (en) 1995-01-27 2009-03-11 Board of Regents, The University of Texas System Methods of enhancing the therapeutic activity of NSAIDs and compositions of zwitterionic phospholipids useful therein
SE9500422D0 (sv) 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US5955451A (en) 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US6132768A (en) 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
US6031549A (en) * 1995-07-19 2000-02-29 Extempo Systems, Inc. System and method for directed improvisation by computer controlled characters
EP0853481A1 (en) 1995-09-27 1998-07-22 Merck Frosst Canada Inc. Compositions for treating inflammation containing certain prostaglandins and a selective cyclooxygenase-2 inhibitor
US5880731A (en) * 1995-12-14 1999-03-09 Microsoft Corporation Use of avatars with automatic gesturing and bounded interaction in on-line chat session
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US20050054682A1 (en) 1996-01-04 2005-03-10 Phillips Jeffrey O. Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE9600072D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US5872145A (en) * 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
US6077539A (en) * 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
TR199901101T2 (xx) 1996-11-22 1999-07-21 The Procter & Gamble Company Gastroenstentinal hastal�klar�n tedavisine y�nelik bizmut ve nsaid i�eren bile�imler.
EP0941101A1 (en) 1996-11-22 1999-09-15 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
SE510666C2 (sv) 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
US6160020A (en) 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
CN1277550A (zh) 1997-09-11 2000-12-20 尼科梅德丹麦有限公司 非甾体抗炎药物(NSAIDs)的改进释放的复合型组合物
CA2307887A1 (en) 1997-10-31 1999-05-14 Monsanto Company Gellan gum tablet coating
IL136285A0 (en) 1997-12-08 2001-05-20 Byk Gulden Lomberg Chem Fab Pharmaceutical compositions containing an acid-labile active component
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
FR2772615B1 (fr) 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
DE19801811B4 (de) 1998-01-19 2004-12-23 Stada Arzneimittel Ag Pharmazeutische Zubereitung zur oralen Verabreichung
WO1999038512A1 (en) 1998-01-30 1999-08-05 Sepracor Inc. S-lansoprazole compositions and methods
WO1999038513A1 (en) 1998-01-30 1999-08-05 Sepracor Inc. R-lansoprazole compositions and methods
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
GB9814215D0 (en) 1998-07-01 1998-09-02 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
US6093734A (en) 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
DE69905380T2 (de) 1998-09-10 2003-11-27 Nycomed Danmark A/S, Roskilde Pharmazeutische zusammensetzungen mit schneller freisetzung von wirkstoffen
US6387410B1 (en) 1998-09-10 2002-05-14 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
US8231899B2 (en) 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US20020090395A1 (en) 1998-09-10 2002-07-11 Austen John Woolfe Anti-inflammatory pharmaceutical formulations
MXPA01003197A (es) 1998-09-28 2004-04-21 Warner Lambert Co Suministro enterico y colonico utilizando capsulas de chpm.
US6485747B1 (en) 1998-10-30 2002-11-26 Monsanto Company Coated active tablet(s)
US6389458B2 (en) * 1998-10-30 2002-05-14 Ideaflood, Inc. Method, apparatus and system for directing access to content on a computer network
SE9803772D0 (sv) 1998-11-05 1998-11-05 Astra Ab Pharmaceutical formulation
US6797283B1 (en) 1998-12-23 2004-09-28 Alza Corporation Gastric retention dosage form having multiple layers
DE19901687B4 (de) 1999-01-18 2006-06-01 Grünenthal GmbH Opioide Analgetika mit kontrollierter Wirkstofffreisetzung
US6183779B1 (en) 1999-03-22 2001-02-06 Pharmascience Inc. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
WO2000057851A2 (en) 1999-03-26 2000-10-05 Pozen Inc. High potency dihydroergotamine compositions
US7546530B1 (en) * 1999-04-15 2009-06-09 Hoshiko Llc Method and apparatus for mapping a site on a wide area network
AU4198899A (en) 1999-05-20 2000-12-12 Par Pharmaceutical, Inc. Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
TWI243672B (en) 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
SE9902386D0 (sv) 1999-06-22 1999-06-22 Astra Ab New formulation
US6126816A (en) 1999-07-14 2000-10-03 Ruiz, Jr.; Reuben F. Wastewater treatment device
CA2277407A1 (en) 1999-07-14 2001-01-14 Bernard Charles Sherman Pharmaceutical tablet comprising an nsaid and misoprostol
US6687746B1 (en) * 1999-08-30 2004-02-03 Ideaflood, Inc. System apparatus and method for hosting and assigning domain names on a wide area network
GB9923436D0 (en) 1999-10-04 1999-12-08 American Home Prod Pharmaceutical compositions
US6763379B1 (en) * 1999-10-14 2004-07-13 Ideaflood, Inc. System, apparatus and method for presenting and displaying content on a wide area network
US8291340B1 (en) * 1999-10-14 2012-10-16 Hoshiko Llc Method and apparatus for providing content to users
US6787164B2 (en) 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
SE0000773D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US7593864B2 (en) * 2000-04-18 2009-09-22 Brian Mark Shuster Method and apparatus for managing ownership of virtual property
US7370110B2 (en) * 2000-04-18 2008-05-06 Hoshiko Llc Method and system for operating a network server to discourage inappropriate use
US6978252B2 (en) * 2000-04-18 2005-12-20 Ideaflood, Inc. Method and system for transacting with network traffic
US6862610B2 (en) * 2000-05-08 2005-03-01 Ideaflood, Inc. Method and apparatus for verifying the identity of individuals
US7228327B2 (en) * 2000-05-08 2007-06-05 Hoshiko Llc Method and apparatus for delivering content via information retrieval devices
US7051362B2 (en) * 2000-05-16 2006-05-23 Ideaflood, Inc. Method and system for operating a network server to discourage inappropriate use
US7428576B2 (en) * 2000-05-16 2008-09-23 Hoshiko Llc Addressee-defined mail addressing system and method
US7200863B2 (en) * 2000-05-16 2007-04-03 Hoshiko Llc System and method for serving content over a wide area network
US20020019800A1 (en) * 2000-05-16 2002-02-14 Ideaflood, Inc. Method and apparatus for transacting divisible property
US7899703B2 (en) * 2000-05-16 2011-03-01 Brian Mark Shuster Method and apparatus for providing internet advertising service
US20020044962A1 (en) 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
US20020022999A1 (en) * 2000-06-23 2002-02-21 Shuster Brian Mark Method and apparatus for providing audio advertisements in a computer network
SE0002476D0 (sv) 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6756879B2 (en) * 2000-07-11 2004-06-29 Ideaflood, Inc. Method and apparatus for securing delivery of goods
US6826546B1 (en) * 2000-08-17 2004-11-30 Ideaflood, Inc. Method and system for licensing a copy of a copyright protected work
US6895236B2 (en) * 2000-08-23 2005-05-17 Ideaflood, Inc. Method for verifying geographical location of wide area network users
US6544556B1 (en) 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
US7029701B2 (en) 2000-09-11 2006-04-18 Andrx Pharmaceuticals, Llc Composition for the treatment and prevention of ischemic events
US20020045184A1 (en) 2000-10-02 2002-04-18 Chih-Ming Chen Packaging system
US6749867B2 (en) 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
US20050020671A1 (en) 2001-02-14 2005-01-27 Matilde Fernandez Ibanez Pharmaceutical formulation
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US7801944B2 (en) * 2001-05-18 2010-09-21 Gary Stephen Shuster Distributed computing using agent embedded in content unrelated to agents processing function
AU2002305758B2 (en) 2001-06-01 2006-09-07 Nuvo Pharmaceuticals (Ireland) Designated Activity Company Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US20100172983A1 (en) * 2001-06-01 2010-07-08 Plachetka John R Pharmaceutical Compositions for the Coordinated Delivery of Naproxen and Esomeprazole
US20030068356A1 (en) 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
AR036354A1 (es) 2001-08-31 2004-09-01 Takeda Chemical Industries Ltd Preparacion solida
US6930099B2 (en) 2001-09-07 2005-08-16 Advanced Medical Instruments Composition for the treatment and prevention of endothelial dysfunction
US7465229B2 (en) * 2002-03-26 2008-12-16 Hoshiko Llc Slot-machine game with adjusting payout table
US20040073439A1 (en) * 2002-03-26 2004-04-15 Ideaflood, Inc. Method and apparatus for issuing a non-transferable ticket
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
FR2845917B1 (fr) 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
US20040121004A1 (en) 2002-12-20 2004-06-24 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
US20040131676A1 (en) 2002-12-20 2004-07-08 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
US20070243251A1 (en) 2002-12-20 2007-10-18 Rajneesh Taneja Dosage Forms Containing A PPI, NSAID, and Buffer
ES2380827T3 (es) * 2002-12-26 2012-05-18 Pozen, Inc. Formas de dosificación con múltiples capas que contienen naproxeno y triptanes
WO2004062552A2 (en) 2003-01-09 2004-07-29 Galephar M/F Pharmaceutical composition containing a nsaid and a benzimidazole derivative
CA2554012A1 (en) 2003-01-21 2004-08-05 Smartrix Technologies Inc. Oral dosage formulation
US8290948B2 (en) * 2003-06-30 2012-10-16 Hoshiko, Llc Method and apparatus for content filtering
US7835294B2 (en) * 2003-09-03 2010-11-16 Gary Stephen Shuster Message filtering method
JP2005145894A (ja) 2003-11-17 2005-06-09 Takeda Chem Ind Ltd 固形製剤
US20050163847A1 (en) 2004-01-21 2005-07-28 Andrx Pharmaceuticals, Llc Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug
WO2005074930A1 (en) 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
WO2005074536A2 (en) 2004-01-30 2005-08-18 Eisai Co., Ltd. Compositions and methods using proton pump inhibitors
WO2005076987A2 (en) * 2004-02-10 2005-08-25 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
US7460737B2 (en) * 2004-02-12 2008-12-02 Hoshiko Llc Method and apparatus for photograph finding
US20050227949A1 (en) 2004-04-07 2005-10-13 Nasrola Edalatpour Compositions and methods for treatment of viral and bacterial infections
US7813917B2 (en) * 2004-06-22 2010-10-12 Gary Stephen Shuster Candidate matching using algorithmic analysis of candidate-authored narrative information
WO2006044202A2 (en) 2004-10-19 2006-04-27 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Enteric coated compositions that release active ingredient(s) in gastric fluid and intestinal fluid
US20060165797A1 (en) 2005-01-12 2006-07-27 Pozen Inc. Dosage form for treating gastrointestinal disorders
US20060178348A1 (en) 2005-01-24 2006-08-10 Pozen Inc. Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an NSAID
US20060178349A1 (en) 2005-01-24 2006-08-10 Pozen Inc. Compositions and therapeutic methods utilizing a combination of a 5-HT1F inhibitor and an NSAID
US20080092065A1 (en) * 2005-02-04 2008-04-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Third party control over virtual world characters
US20070013691A1 (en) * 2005-07-18 2007-01-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Supervisory authority in virtual world environment
US8566111B2 (en) * 2005-02-04 2013-10-22 The Invention Science Fund I, Llc Disposition of component virtual property rights
US20060177504A1 (en) 2005-02-08 2006-08-10 Renjit Sundharadas Combination pain medication
EP1726300A1 (en) 2005-05-24 2006-11-29 Flamel Technologies Oral pharmaceutical formulation for the prevention and/or the treatment of cardiovascular and inflammatory diseases
EP1726301A1 (en) 2005-05-24 2006-11-29 Flamel Technologies Oral pharmaceutical composition for treating a COX-2 mediated condition
WO2007030710A2 (en) * 2005-09-08 2007-03-15 Hoshiko, Llc Gaming method
US8594084B2 (en) * 2005-09-09 2013-11-26 Intellectual Ventures I Llc Network router security method
WO2007035611A2 (en) * 2005-09-16 2007-03-29 Hoshiko, Llc Low power mode for portable computer system
US7874521B2 (en) * 2005-10-17 2011-01-25 Hoshiko Llc Method and system for aviation navigation
US10148905B2 (en) * 2005-10-19 2018-12-04 Intellectual Ventures I Llc Digital medium with hidden content
US20070093232A1 (en) * 2005-10-21 2007-04-26 Shuster Gary S Management of an alert signal for a telecommunications device
US8577698B2 (en) * 2005-10-25 2013-11-05 Intellectual Ventures I Llc Retail price hedging
US7937320B2 (en) * 2005-11-14 2011-05-03 Hoshiko, Llc Managed purchasing account for defined commodities
AR057181A1 (es) 2005-11-30 2007-11-21 Astra Ab Nueva forma de dosificacion de combinacion
EP1965774A2 (en) 2005-12-30 2008-09-10 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
CN101410095B (zh) 2006-03-06 2015-07-01 波曾公司 施用组合药物的剂型
US7744464B2 (en) * 2006-09-19 2010-06-29 Gary Stephen Shuster Method of managing a card game, a computer implementation thereof, and a card game kit
US8683386B2 (en) * 2006-10-03 2014-03-25 Brian Mark Shuster Virtual environment for computer game
CA2667682A1 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
US7803042B2 (en) * 2007-01-17 2010-09-28 Gary Stephen Shuster Card game with common card removal
US20100221337A1 (en) * 2007-02-14 2010-09-02 Logical Therapeutics, Inc. Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and an h2 receptor antagonist
CA2685353C (en) * 2007-03-07 2016-04-26 Ideaflood, Inc. Multi-instance, multi-user animation platforms
US20080031950A1 (en) * 2007-04-27 2008-02-07 Nectid Inc. Novel anelgesic combination
US7914144B2 (en) * 2007-05-02 2011-03-29 Gary Stephen Shuster Eyewear with pinhole aperture and lens
US7804744B2 (en) * 2007-05-03 2010-09-28 Gary Stephen Shuster Optically-readable disk with copy protection device
US7916619B2 (en) * 2007-05-03 2011-03-29 Gary Stephen Shuster Optically-readable disk with copy protection device
US8126971B2 (en) * 2007-05-07 2012-02-28 Gary Stephen Shuster E-mail authentication
WO2009012393A1 (en) 2007-07-18 2009-01-22 The Curators Of The University Of Missouri Pharmaceutical composition comprising a proton pump inhibitor and protein component
US7769806B2 (en) * 2007-10-24 2010-08-03 Social Communications Company Automated real-time data stream switching in a shared virtual area communication environment
US7809789B2 (en) * 2007-10-25 2010-10-05 Brian Mark Shuster Multi-user animation coupled to bulletin board
US8049756B2 (en) * 2007-10-30 2011-11-01 Brian Mark Shuster Time-dependent client inactivity indicia in a multi-user animation environment
EP2364145A4 (en) 2008-05-30 2013-11-13 Pozen Inc GALENIC FORMS FOR RAPID AND EXTENDED ELEVATION OF GASTRIC PH
US20100005028A1 (en) * 2008-07-07 2010-01-07 International Business Machines Corporation Method and apparatus for interconnecting a plurality of virtual world environments
US8471843B2 (en) * 2008-07-07 2013-06-25 International Business Machines Corporation Geometric and texture modifications of objects in a virtual universe based on real world user characteristics
US9268385B2 (en) * 2008-08-20 2016-02-23 International Business Machines Corporation Introducing selective energy efficiency in a virtual environment
US9220698B2 (en) * 2008-09-09 2015-12-29 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
US8108774B2 (en) * 2008-09-26 2012-01-31 International Business Machines Corporation Avatar appearance transformation in a virtual universe
EP2445344A4 (en) 2009-06-25 2013-01-23 Pozen Inc METHOD FOR THE TREATMENT OF A PATIENT REQUIRED BY ASPIRIN THERAPY
US9610502B2 (en) * 2009-07-10 2017-04-04 International Business Machines Corporation Use of real time location information for user authentication and authorization in virtual environments
US8893000B2 (en) * 2009-08-26 2014-11-18 International Business Machines Corporation Relocation between virtual environments based upon promotional and alert conditions
US9785909B2 (en) * 2009-08-27 2017-10-10 International Business Machines Corporation Preventing propagation of malicious content in a virtual universe
US9256896B2 (en) * 2009-08-27 2016-02-09 International Business Machines Corporation Virtual universe rendering based on prioritized metadata terms
US20110047828A1 (en) * 2009-09-02 2011-03-03 Gary Stephen Shuster Remotely controlled footwear disruptor
US20120030289A1 (en) * 2010-07-30 2012-02-02 Avaya Inc. System and method for multi-model, context-sensitive, real-time collaboration
US8717447B2 (en) * 2010-08-20 2014-05-06 Gary Stephen Shuster Remote telepresence gaze direction
US8949964B2 (en) * 2010-08-25 2015-02-03 Gary Stephen Shuster Security key entry using ancillary input device
US20120059886A1 (en) * 2010-08-30 2012-03-08 Gary Stephen Shuster Reply message handling for transient group
US20140372912A9 (en) * 2010-10-30 2014-12-18 Aaron D. Cohen Multi-Dimensional Enhanced World View Experiences, Related Systems and Software, Methods of Use and Production Thereof
EP2745462B1 (en) * 2011-08-18 2021-10-20 Pfaqutruma Research LLC Systems and methods of virtual world interaction

Similar Documents

Publication Publication Date Title
JP2012531409A5 (2)
JP2012502015A5 (2)
US10603283B2 (en) Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
JP6746612B2 (ja) メロキシカムを含む医薬組成物
TW452495B (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
Horn relationship between the metabolism and efficacy of proton pump inhibitors–focus on rabeprazole
JP2011500595A5 (2)
JP2012531430A5 (2)
Skrzydło-Radomańska et al. Dexlansoprazole–a new-generation proton pump inhibitor
JP2016164165A5 (2)
CA2449098A1 (en) Pharmaceutical compositions for the coordinated delivery of nsaids
JP2008505054A5 (2)
Schellack An overview of gastropathy induced by nonsteroidal anti-inflammatory drugs: evidence-based pharmacy practice
NZ597534A (en) Method for treating a patient in need of aspirin therapy
JP2009517466A5 (2)
CN101184482A (zh) 抑制胃酸分泌的组合物和方法
CN107530335A (zh) 新型药学用途
CN1744897A (zh) 结合有泰妥拉唑与消炎剂的药物组合物
CA2605839A1 (en) Stabilized composition of a proton pump inhibitor
JP2011520868A (ja) 胃酸分泌を阻害するための組成物および方法
KR102289011B1 (ko) 비스테로이드성 항염증제 및 프로톤 펌프 저해제를 포함하는 경구용 서방성 복합제제
JP5303093B2 (ja) テナトプラゾール及びヒスタミンh2受容体拮抗剤を組み合わせた医薬組成物
WO2007129178A2 (en) Pharmaceutical compositions comprising non-steroidal antiinflammatory drug, antipyretic- analgesic drug and proton pump inhibitor
CN102920705A (zh) 泰妥拉唑在制造治疗胃食管反流性疾病的药物中的应用
CA3275148A1 (en) Pharmaceutical composition for prevention or treatment of drug-related peptic ulcer comprising zastaprazan or pharmaceutically acceptable salt thereof